Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19
December 23, 2021
Tickers
GILD
From Benzinga
Mereo BioPharma's Alvelestat Shows Improvement In COVID-19 Severity
December 22, 2021
Tickers
MREO
From Benzinga
FDA To Possibly Authorize Pfizer, Merck COVID-19 Antiviral Pills This Week: Bloomberg
December 22, 2021
From Benzinga
UK Calls For Additional Doses Of COVID-19 Antivirals From Merck, Pfizer
December 22, 2021
From Benzinga
BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody
December 22, 2021
Tickers
BVXV
From Benzinga
Novavax Initiates Phase 3 COVID-19 Vaccine Booster Study
December 22, 2021
Tickers
NVAX
From Benzinga
European Commission Expands Use Of Remdesivir In COVID-19 Patients Not On Supplemental Oxygen
December 21, 2021
Tickers
GILD
From Benzinga
Aridis Stock Rallies After Positive Preclinical Data For COVID-19 Antibody Against Omicron
December 21, 2021
Tickers
ARDS
From Benzinga
Novavax's COVID-19 Vaccine Scores Conditional Approval In Europe
December 20, 2021
Tickers
NVAX
From Benzinga
Moderna's Authorized COVID-19 Booster Increases Omicron Neutralizing Antibody Levels 37-Fold
December 20, 2021
Tickers
MRNA
From Benzinga
Pfizer Plans To Evaluate Third Shot For Its COVID-19 Vaccine In Kids Below 5 Years
December 17, 2021
From Benzinga
From Benzinga
CDC Backs mRNA COVID-19 Vaccines Over Johnson & Johnson's, Citing Higher Rates Of Clotting Cases: Report
December 17, 2021
From Benzinga
From Benzinga
Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
December 17, 2021
From Benzinga
Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15
December 17, 2021
From Benzinga
AstraZeneca's COVID-19 Antibody Effective Against Omicron Variant
December 16, 2021
From Benzinga
EMA Offers Early Access To Pfizer's COVID-19 Pill Paxlovid
December 16, 2021
Tickers
PFE
From Benzinga
From Benzinga
Valneva's COVID-19 Vaccine Booster Works As A Follow-Up To Its Own Shot
December 16, 2021
Tickers
VALN
From Benzinga
FDA Lab Testing Confirms SAB Biotherapeutics' COVID-19 Antibody Neutralizes Omicron Variant
December 16, 2021
Tickers
SABS
From Benzinga
Novavax Files For Approval Of Its COVID-19 Vaccine In Japan
December 16, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
